We are live on ! Find out more
OPXAW

Opexa Therapeutics, Inc.
OPXAW

Delisted

OPXAW was delisted on the 20th of September, 2017.

Back to rankings

4 hedge funds and large institutions have $41K invested in Opexa Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 5 → 4 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

77% less capital invested

Capital invested by funds: $176K → $41K (-$135K)

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$5.71K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2K
2
UBS Group
UBS Group
Switzerland
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$32K – – –
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$5K – – –
VKH
3
Virtu KCG Holdings
New York
$3K +$5.71K +148,288 New
EEG
4
E.E. Geduld
$1K – – –
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
– -$2K -18,596 Closed
UBS Group
6
UBS Group
Switzerland
– -$1K -7,161 Closed

OPXAW Hedge Fund Activity: Q4 2016 in Review

4 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Opexa Therapeutics, Inc. (OPXAW) for Q4 2016, worth a combined $41K — down 77% from $176K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of OPXAW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $5.71K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $2K sold.

  • 4 institutional investors held Opexa Therapeutics, Inc. (OPXAW) as of Q4 2016, down from 5 in Q3 2016.
  • Funds reported $41K of Opexa Therapeutics, Inc. stock for Q4 2016, down 77% quarter-over-quarter.
  • 1 fund opened new Opexa Therapeutics, Inc. positions in Q4 2016 and 2 closed out, a net change of -1 holder.
  • The largest Opexa Therapeutics, Inc. buyer in Q4 2016 was Virtu KCG Holdings, an estimated $5.71K added.
  • The largest Opexa Therapeutics, Inc. seller in Q4 2016 was Susquehanna International Group, an estimated $2K sold.

Based on aggregated 13F filings for Q4 2016.